No Data
Xiangyu Medical (688626.SH): First-time repurchase of 0.1058 million shares.
On November 26, Gelunhui reported that Xiangyu Medical (688626.SH) announced that on November 26, 2024, the company repurchased 105,800 shares of the company for the first time through the Shanghai Stock Exchange trading system using centralized bidding trading method, accounting for 0.0661% of the company's total share capital of 160,000,000 shares. The highest price of the repurchase transaction was 31.20 yuan/share, the lowest price was 30.80 yuan/share, and the total amount paid was 3,271,257.28 yuan (excluding transaction fees such as trading commissions and transfer fees).
The delay in bidding at the hospital end has negatively impacted revenue. Xiangyu Medical is cultivating a second growth curve, with brain-machine products expected to be available for sale as early as this year.
① Due to delays in the bidding activities at the hospital level, Xiangyu Medical experienced a decline in revenue in the first three quarters of 2024. The company is increasing its marketing efforts in areas such as military, exports, home care, private health care, and off-site services; ② Xiangyu Medical's layout in brain-computer interfaces is mainly focused on non-invasive rehabilitation devices, with mental health products expected to be market-ready as early as this year.
Xiangyu Medical to Buy Back Up to 100 Million Yuan of Shares
There Might Be More To Xiangyu MedicalLtd's (SHSE:688626) Story Than Just Weak Earnings
Xiangyu Medical Report for the Third Quarter of 2024
Shanghai Xiangyu Medical (688626.SH): The net income in the first three quarters was 73.4139 million yuan, a year-on-year decrease of 59.02%.
Health Times October 29th丨Xiangyu Medical (688626.SH) announced that in the first three quarters of 2024, revenue reached 0.507 billion yuan, a decrease of 6.50% year-on-year; net income attributable to shareholders of the listed company was 73.4139 million yuan, a decrease of 59.02% year-on-year; basic earnings per share was 0.47 yuan.
Investors Aren't Buying Xiangyu Medical Co.,Ltd's (SHSE:688626) Earnings
